Arrowhead Pharmaceuticals Insider Trades
NASDAQ: ARWRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 62.75 0.00%
Last 12 months
- Purchases
- 0 · $0
- Sales
- 64 · $37.34M
- Shares bought / sold
- 0 / 560.50K
- Net activity
- Net selling $37.3 million
Arrowhead Pharmaceuticals insider activity
Over the last 12 months, Arrowhead Pharmaceuticals insiders reported 88 transactions on SEC Form 4: 0 open-market purchases and 64 sales. Insiders bought $0 and sold $37.3 million worth of stock, for net insider selling of $37.3 million. The largest seller was Anzalone Christopher Richard, with $24.0 million in reported sales.
The most recent filing shows OLUKOTUN ADEOYE Y (Director) selling 2,000 shares at $86.96 on Aug 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ARWR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ARWR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 18, 2026 | PERRY MICHAEL SDirector | Sale | 11,600 | $1.01M | Form 4 |
| Aug 18, 2026 | OLUKOTUN ADEOYE YDirector | Sale | 2,000 | $173.92K | Form 4 |
| Jun 15, 2026 | Cohen Matthew GregoryDirector | Award | 11,882 | — | Form 4 |
| May 12, 2026 | Lu HongboDirector | Sale | 2,970 | $228.33K | Form 4 |
| Apr 23, 2026 | Hamilton James CChief Medical Officer | Sale | 10,000 | $750.00K | Form 4 |
| Apr 22, 2026 | Apel Daniel JosephChief Financial Officer | Sale | 8,730 | $627.86K | Form 4 |
| Apr 22, 2026 | Apel Daniel JosephChief Financial Officer | Sale | 1,157 | $81.51K | Form 4 |
| Apr 22, 2026 | Apel Daniel JosephChief Financial Officer | Sale | 3,208 | $224.91K | Form 4 |
| Mar 5, 2026 | Hamilton James CChief Medical Officer | Sale | 10,000 | $641.90K | Form 4 |
| Jan 6, 2026 | O'Brien PatrickCOO | Award | 75,000 | — | Form 4 |
| Jan 6, 2026 | O'Brien PatrickCOO | Gift | 440 | — | Form 4 |
| Jan 6, 2026 | O'Brien PatrickCOO | Gift | 440 | — | Form 4 |
| Jan 6, 2026 | O'Brien PatrickCOO | Gift | 540 | — | Form 4 |
| Jan 6, 2026 | O'Brien PatrickCOO | Gift | 540 | — | Form 4 |
| Jan 6, 2026 | O'Brien PatrickCOO | Gift | 540 | — | Form 4 |
| Jan 6, 2026 | Hamilton James CChief Medical Officer | Award | 75,000 | — | Form 4 |
| Jan 6, 2026 | Apel Daniel JosephChief Financial Officer | Award | 75,000 | — | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 46 | $3.13K | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 2,336 | $149.60K | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 5,873 | $369.47K | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 900 | $56.02K | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 600 | $36.67K | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 313 | $21.28K | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 900 | $59.41K | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 2,700 | $173.99K | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 11,842 | $755.99K | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 13,451 | $846.87K | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 6,164 | $383.59K | Form 4 |
| Jan 5, 2026 | O'Brien PatrickCOO | Sale | 4,368 | $267.32K | Form 4 |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sale | 309 | $21.01K | Form 4 |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sale | 437 | $28.83K | Form 4 |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sale | 1,200 | $77.39K | Form 4 |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sale | 12,711 | $812.87K | Form 4 |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sale | 14,792 | $932.04K | Form 4 |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sale | 6,090 | $379.29K | Form 4 |
| Jan 5, 2026 | Hamilton James CChief Medical Officer | Sale | 4,625 | $283.24K | Form 4 |
| Jan 2, 2026 | Anzalone Christopher RichardChief Executive Officer | Sale | 5,771 | $383.14K | Form 4 |
| Jan 2, 2026 | Anzalone Christopher RichardChief Executive Officer | Sale | 7,416 | $488.57K | Form 4 |
| Dec 31, 2025 | O'Brien PatrickCOO | Gift | 560 | — | Form 4 |
| Dec 31, 2025 | O'Brien PatrickCOO | Gift | 560 | — | Form 4 |
| Dec 31, 2025 | O'Brien PatrickCOO | Gift | 560 | — | Form 4 |
| Dec 31, 2025 | O'Brien PatrickCOO | Gift | 560 | — | Form 4 |
| Dec 31, 2025 | O'Brien PatrickCOO | Gift | 560 | — | Form 4 |
| Dec 29, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 16,545 | $1.14M | Form 4 |
| Dec 29, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 35,181 | $2.44M | Form 4 |
| Dec 29, 2025 | Anzalone Christopher RichardChief Executive Officer | Option exercise | 16,545 | $101.75K | Form 4 |
| Dec 29, 2025 | Anzalone Christopher RichardChief Executive Officer | Option exercise | 35,181 | $216.36K | Form 4 |
| Dec 26, 2025 | Ferrari MauroDirector | Sale | 7,530 | $527.10K | Form 4 |
| Dec 22, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 2,574 | $177.22K | Form 4 |
| Dec 22, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 10,012 | $684.12K | Form 4 |
| Dec 19, 2025 | OLUKOTUN ADEOYE YDirector | Sale | 827 | $56.63K | Form 4 |
| Dec 19, 2025 | OLUKOTUN ADEOYE YDirector | Sale | 6,083 | $413.89K | Form 4 |
| Dec 19, 2025 | OLUKOTUN ADEOYE YDirector | Sale | 3,090 | $206.10K | Form 4 |
| Dec 19, 2025 | Vakiener VictoriaDirector | Sale | 1,960 | $134.04K | Form 4 |
| Dec 19, 2025 | Vakiener VictoriaDirector | Sale | 5,281 | $358.95K | Form 4 |
| Dec 19, 2025 | Vakiener VictoriaDirector | Sale | 2,799 | $186.50K | Form 4 |
| Dec 19, 2025 | Waddill William D.Director | Sale | 500 | $34.27K | Form 4 |
| Dec 19, 2025 | Waddill William D.Director | Sale | 5,451 | $370.72K | Form 4 |
| Dec 19, 2025 | Waddill William D.Director | Sale | 2,416 | $161.05K | Form 4 |
| Dec 19, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 1,319 | $90.33K | Form 4 |
| Dec 19, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 8,147 | $554.08K | Form 4 |
| Dec 19, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 3,979 | $265.28K | Form 4 |
| Dec 17, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 1,981 | $131.34K | Form 4 |
| Dec 17, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 982 | $64.35K | Form 4 |
| Dec 17, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 35,750 | $2.31M | Form 4 |
| Dec 17, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 46,287 | $2.94M | Form 4 |
| Dec 16, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 3,221 | $218.61K | Form 4 |
| Dec 16, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 166 | $11.08K | Form 4 |
| Dec 16, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 1,300 | $85.50K | Form 4 |
| Dec 16, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 1,000 | $64.96K | Form 4 |
| Dec 16, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 6,661 | $428.24K | Form 4 |
| Dec 16, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 8,476 | $533.48K | Form 4 |
| Dec 16, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 14,095 | $875.58K | Form 4 |
| Dec 16, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 10,963 | $671.48K | Form 4 |
| Dec 16, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 8,416 | $509.25K | Form 4 |
| Dec 16, 2025 | Waddill William D.Director | Award | 7,819 | — | Form 4 |
| Dec 16, 2025 | OLUKOTUN ADEOYE YDirector | Award | 7,819 | — | Form 4 |
| Dec 16, 2025 | INGRAM DOUGLAS SDirector | Award | 7,819 | — | Form 4 |
| Dec 16, 2025 | Vakiener VictoriaDirector | Award | 7,819 | — | Form 4 |
| Dec 16, 2025 | Lu HongboDirector | Award | 7,819 | — | Form 4 |
| Dec 16, 2025 | PERRY MICHAEL SDirector | Award | 7,819 | — | Form 4 |
| Dec 16, 2025 | Ferrari MauroDirector | Award | 7,819 | — | Form 4 |
| Dec 15, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 8,147 | $569.96K | Form 4 |
| Dec 15, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 21,321 | $1.48M | Form 4 |
| Dec 15, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 100,532 | $6.90M | Form 4 |
| Dec 12, 2025 | Anzalone Christopher RichardChief Executive Officer | Award | 180,000 | — | Form 4 |
| Dec 5, 2025 | PERRY MICHAEL SDirector | Sale | 16,250 | $991.74K | Form 4 |
| Nov 28, 2025 | Ferrari MauroDirector | Sale | 8,750 | $493.41K | Form 4 |
| Oct 1, 2025 | Hamilton James CChief Medical Officer | Sale | 20,000 | $700.00K | Form 4 |
| Sep 12, 2025 | Hamilton James CChief Medical Officer | Sale | 15,000 | $450.00K | Form 4 |
| Sep 2, 2025 | Hamilton James CChief Medical Officer | Sale | 15,000 | $375.00K | Form 4 |
| Aug 15, 2025 | Hamilton James CChief Medical Officer | Sale | 9,389 | $187.78K | Form 4 |
| Aug 13, 2025 | Hamilton James CChief Medical Officer | Sale | 611 | $12.22K | Form 4 |
| Apr 11, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 50,800 | $583.69K | Form 4 |
| Apr 10, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 50,000 | $543.50K | Form 4 |
| Apr 9, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 1,617 | $19.02K | Form 4 |
| Apr 9, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 3,400 | $36.55K | Form 4 |
| Apr 9, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 35,305 | $350.58K | Form 4 |
| Mar 13, 2025 | Anzalone Christopher RichardChief Executive Officer | Sale | 51,425 | $774.97K | Form 4 |
| Mar 13, 2025 | Anzalone Christopher RichardChief Executive Officer | Award | 340,000 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4